Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Generation Bio Co is a biotechnology business based in the US. Generation Bio Co shares (GBIO) are listed on the NASDAQ and all prices are listed in US Dollars. Generation Bio Co employs 150 staff and has a market cap (total outstanding shares value) of 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $6.62 |
|---|---|
| 52-week range | $3.96 - $28.67 |
| 50-day moving average | $6.18 |
| 200-day moving average | $11.35 |
| Wall St. target price | $22.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.27 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $6.62 from 2022-06-29
| 1 week (2022-06-23) | -5.70% |
|---|---|
| 1 month (2022-05-27) | 22.14% |
| 3 months (2022-03-30) | -7.93% |
| 6 months (2021-12-30) | -7.15% |
| 1 year (2021-06-30) | -75.39% |
|---|---|
| 2 years (2020-06-30) | -68.48% |
| 3 years (2019-06-26) | N/A |
| 5 years (2017-06-26) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -16.8% |
| Return on equity TTM | -31.69% |
| Profit margin | 0% |
| Book value | $6.19 |
| Market capitalisation | $399.6 million |
TTM: trailing 12 months
We're not expecting Generation Bio Co to pay a dividend over the next 12 months.
Over the last 12 months, Generation Bio Co's shares have ranged in value from as little as $3.96 up to $28.665. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Generation Bio Co's is 2.8656. This would suggest that Generation Bio Co's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Generation Bio Co. , a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.